Jacob Grønnegaard of FujiFilm Diosynth Biotechnologies discussed how the company’s unique cloning processes dramatically reduce project execution time, effort and expense at Emerson Exchange Immerse event. The result is intended to be one of the top medicine production facilities in the country. Hopefully, it won’t have to ramp up production for a virus vaccine to combat a worldwide pandemic, but if the time ever comes again, it will be scalable and ready.
Latest News
Leading Korean Carbon Tech Company Selects Emerson as Automation Partner
Collaboration will advance carbon capture technologies to help Korean energy sector thrive in a sustainability-focused market
Emerson Introduces Gas Chromatograph for Natural Gas, Biogas, Renewable Gas Measurement and...
Rosemount 470XA provides a compact and cost-effective solution for custody transfer, carbon capture and other applications of traditional and...
Emerson to Spotlight Sustainability Progress at COP29
Industrial technology leader will showcase innovations accelerating energy management, emissions reduction and decarbonization
